Clairways provides smart lung monitoring for pharmaceutical clinical trials.
Clairways has raised $1000K in total funding. The most recent round was Grant. The last funding was announced in September 2021.
Clairways's investors include National Science Foundation.
Clairways is headquartered in Lebanon, United States.
Clairways provides smart lung monitoring for pharmaceutical clinical trials.
Clairways is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clairways — Funding & Investors." VCBacked, September 10, 2021, https://www.vcbacked.co/company/clairways. Accessed September 30, 2026.
VCBacked. (2021). Clairways — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/clairways
{{cite web |title=Clairways — Funding & Investors |url=https://www.vcbacked.co/company/clairways |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated